sCD14 pre-LT and Graft Loss.

<p>Proportional hazards regression models for graft loss were developed. Univariate analyses were performed with each biomarker singly (upper panel); multivariate models were developed that incorporated known predictors of graft loss and biomarkers found in the univariate analysis.</p

Characteristics of HCV-HIV Coinfected Liver Transplant Recipients.

<p>^a Most recent pre-transplant value, within 16 weeks of transplant.</p><p>LT—liver transplantation;</p><p>Characteristics of HCV-HIV Coinfected Liver Transplant Recipients.</p

Univariate and Multivariate Proportional Hazards Regression Models for Treated Acute Rejection.

<p>Abbreviation: HR, Hazard Ratio</p><p>^a Baseline predictor (log-scale)</p><p>^b Incorporated known predictors of treated acute rejection and biomarkers found in the univariate analysis.</p><p>^c Post-transplant (time-varying covariate)</p><p>Univariate and Multivariate Proportional Hazards Regression Models for Treated Acute Rejection.</p

HIV RNA Levels Pre-LT and Immune Activation.

<p>Full immunologic profile was performed using the MSD platform, while IP-10 levels were measured by ELISA. Persons with detectable HIV RNA pre-LT had higher levels of IL-2 (p = 0.01), IL-5 (p = 0.02), IL-10 (p = 0.01), and IP-10 (p = 0.01), by Wilcoxon rank-sum test.</p

Univariate and Multivariate Proportional Hazards Regression Models for Graft Loss.

<p>Abbreviation: HR, Hazard Ratio</p><p>^a Baseline predictor (log-scale)</p><p>^b Incorporated known predictors of graft loss and biomarkers found in the univariate analysis.</p><p>Univariate and Multivariate Proportional Hazards Regression Models for Graft Loss.</p

sCD14 Levels Pre-LT.

<p>sCD14 levels were measured by ELISA in 69 HIV-HCV co-infected persons pre-LT; graft loss post-LT occurred in 35/69 (51%) persons. In a univariate Cox regression model, higher sCD14 levels pre-LT were marginally associated with lower risk of graft loss post-LT (p = 0.08).</p